Where does Brainsway Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Brainsway Ltd. ranks #18,454 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Brainsway Ltd. hold?

Brainsway Ltd. holds 15 US utility patents granted between 2015 and 2025, spanning 4 technology areas.

What is Brainsway Ltd.'s Innovation Score?

Brainsway Ltd. has an Innovation Score of 33.4 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Brainsway Ltd. focus on?

Brainsway Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 15 patents, ranking #244 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Brainsway Ltd.'s patent grant rate increasing or decreasing?

Brainsway Ltd.'s recent grant velocity is -44% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Brainsway Ltd.'s patents?

Brainsway Ltd.'s patents average 22.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Brainsway Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Brainsway Ltd.

USPTO PatentsView assignee record - 15 granted patents across 4 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Brainsway ranks #18,454 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 4 technology areas.

#18,454
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.4/100): 22.4
avg claims per patent: -44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18454 · Foreign Corporation #18,454 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,454/49,997
PHOTO-FINISH Balboa Water Group
CPC-NARROW A61N · 4 areas
INNOV-THIN 33.4/100
CLAIMS-DENSE 22.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -44% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Balboa Water Group, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Brainsway’s 33.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (29%) Velocity 3.3 pts (10%) Breadth 7.1 pts (21%) Claim depth 13.4 pts (40%)

Qualcomm Incorporated · highest

85
Brainsway · this assignee

33
3D Lighting… · lowest

7

What this shows Brainsway's Innovation Score is 33.4/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Brainsway?

Each dot is one of Brainsway’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Brainsway’s own 22.4 claims/patent is ABOVE the 4.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Brainsway vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Brainsway's grants concentrate

Brainsway Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2015. By volume, Brainsway sits between Bondtech Co., Ltd. and Bellicon AG.

Brainsway's three-year grant acceleration

Brainsway Ltd. shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bondtech

15
Bonumose

15
Bormioli Rocco S…

15
Botanic Experienc…

15
Balboa Water Group

15
Bay City Flower

15
Beijing Universit…

15
Bellicon

15
Brainsway ◀

15

What this shows Brainsway holds 15 patents at rank #18,439, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Brainsway

By rank, the assignees closest to #18,439 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Brainsway's primary technology class.

Brainsway's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Brainsway Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	6.7%
2016	2	13.3%
2017	4	26.7%
2018	1	6.7%
2019	1	6.7%
2020	2	13.3%
2021	1	6.7%
2022	2	13.3%
2025partial year	1	6.7%

Which technologies does Brainsway Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 15

A61B - DIAGNOSIS; SURGERY; Identification 2

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Brainsway Ltd.'s patent record in context - here's where to go next.

Brainsway Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #18,454 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Brainsway Ltd. against Bondtech Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.